Thank You for reading

We have just posted a new story

• Engineering new AAV vectors for gene therapy. German researchers have made a system to rapidly spit out AAV delivery vectors for carrying gene therapy tools like CRISPR to the cell types of your choice.

Related post on AAVs and CRISPR

• AAV delivery and safety. A talk with Bence György about AAV chromosomal DNA integration in high frequency using CRISPR.

Did you miss?

• Last weeks piece on the first news from China on a CRISPR cancer therapy trial. The good news is CRISPR-Cas9-edited T cells appear to be feasible, and safe and so the stage is set for the next significant advances in cancer treatment. Comments by leading experts Carl June, Waseem Qasim, and Inge Marie Svane.

Thank You for now - more great reads are on the way.

And if you have questions or suggestions, you can directly reach us at editor@crisprmedicinenews.com. We love hearing from readers!

(c; Rasmus

NB Did You notice the new email? We are growing, and the subtle name-change fit our up-and-coming CRISPR medicine news site identity better than 'blog'. And yes, it is not just a name-change - you can look forward to new initiatives soon to be revealed.

You can follow the blog on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up yourself here.